London
· Delayed Price · Currency is GBP · Price in USD Mereo BioPharma Group Statistics
Total Valuation
LON:0A9G has a market cap or net worth of GBP 322.69 million. The enterprise value is 276.96 million.
| Market Cap | 322.69M |
| Enterprise Value | 276.96M |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +12.10% |
| Shares Change (QoQ) | +1.19% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 101.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 6.94 |
| P/TBV Ratio | 7.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.58 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -10.78 |
Financial Position
The company has a current ratio of 8.92, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.92 |
| Quick Ratio | 8.65 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -38.15 |
Financial Efficiency
Return on equity (ROE) is -91.70% and return on invested capital (ROIC) is -53.91%.
| Return on Equity (ROE) | -91.70% |
| Return on Assets (ROA) | -47.59% |
| Return on Invested Capital (ROIC) | -53.91% |
| Return on Capital Employed (ROCE) | -77.78% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.01M |
| Employee Count | 36 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.48% in the last 52 weeks. The beta is 0.35, so LON:0A9G's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | -30.48% |
| 50-Day Moving Average | 2.38 |
| 200-Day Moving Average | 3.27 |
| Relative Strength Index (RSI) | 60.89 |
| Average Volume (20 Days) | 7,027 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.86 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -36.62M |
| Pretax Income | -36.52M |
| Net Income | -36.52M |
| EBITDA | -36.17M |
| EBIT | -36.62M |
| Earnings Per Share (EPS) | -0.24 |
Balance Sheet
The company has 48.36 million in cash and 578,171 in debt, giving a net cash position of 47.78 million.
| Cash & Cash Equivalents | 48.36M |
| Total Debt | 578,171 |
| Net Cash | 47.78M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 46.50M |
| Book Value Per Share | 0.29 |
| Working Capital | 45.98M |
Cash Flow
In the last 12 months, operating cash flow was -25.67 million and capital expenditures -15,480, giving a free cash flow of -25.69 million.
| Operating Cash Flow | -25.67M |
| Capital Expenditures | -15,480 |
| Free Cash Flow | -25.69M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LON:0A9G does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.10% |
| Shareholder Yield | n/a |
| Earnings Yield | -11.32% |
| FCF Yield | -7.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |